Prosecution Insights
Last updated: October 27, 2026

Imperial College Innovations Limited

Technology area: Biotechnology & Pharmaceuticals

32 pending office actions • 24 art units • 31 examiners • 0 of 32 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days

Analysis

Imperial College Innovations Limited has 35 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 34 distinct examiners and 25 art units, indicating broad distribution across examination teams and technical assignments.

LANDSMAN, ROBERT S is the busiest examiner, with 2 pending actions. The limited concentration means the portfolio cannot be managed through a single examiner strategy, although those matters may still provide a useful checkpoint for recurring issues.

Counsel should use coordinated standards for claim terminology, written-description support, and amendment positions while preserving application-level analysis. The breadth of examiner and art-unit coverage also favors systematic tracking of cited art, prosecution arguments, and interview outcomes across the biotechnology and pharmaceutical docket.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

32
Total Pending OAs
20
Non-Final OAs
10
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (3)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

22
Hard (69%)
8
Medium (25%)
2
Easy (6%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other7 (22%)
§103 only6 (19%)
§102 only1 (3%)
§112 only2 (6%)
Double-patenting + other1 (3%)
Multi-statute (no §101)15 (47%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

23
Life Sciences
72% of docket
1
Information Tech
3% of docket
1
Communications
3% of docket
1
Semiconductors
3% of docket
6
Mechanical / Eng
19% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

320 h
Manual time on pending OAs
64 h
Time saved (low, 20%)
112 h
Time saved (mid, 35%)
2.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LANDSMAN, ROBERT S 2 81.4% +13.0%
MCANDREW, CHRISTOPHER P 1 86.0% +13.8%
HANEY, JONATHAN MICHAEL 1 56.9% +54.5%
PHAM, ANNIE 1 90.0% +11.1%
NGUYEN, THUY-VI THI 1 51.9% +11.3%
WILDER, CYNTHIA B 1 70.8% +27.0%
SPENCE, JENNIFER SUZANNE 1 66.9% +46.0%
RAGHU, GANAPATHIRAM 1 73.7% +26.5%
GOLDBERG, JEANINE ANNE 1 45.4% +40.5%
SHOMER, ISAAC 1 63.1% +30.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18951088 METHOD OF DETERMINING AN ARRANGEMENT FOR OBJECTS PHAM, ANNIE —

Hard Cases (22)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17798921 DETECTION OF COGNITIVE IMPAIRMENT IN HUMAN BRAINS FROM IMAGES BARNES JR, CARL E 45d overdue
18042965 A METHOD FOR DETERMINING A DIAGNOSTIC OUTCOME CHUNDURU, SURYAPRABHA 44d overdue
17906602 DEVICE FOR PERFUSION AND PRESERVATION OF TISSUE SPECIMENS EX VIVO KOSAR, AARON J 36d overdue
17753496 APPARATUS AND METHOD SISON, CHRISTINE ANDREA PAN 18d overdue
18570611 SUB-MICRON PARTICLE SHOMER, ISAAC 12d
18248285 METHODS AND MEANS FOR AMPLIFICATION-BASED QUANTIFICATION OF NUCLEIC ACIDS GIAMMONA, FRANCESCA FILIPPA 14d
17762931 METHOD FOR ISOLATING EXTRACELLULAR VESICLES ZINGARELLI, SANDRA 34d
19106247 METHOD AND APPARATUS FOR REDUCING THE NOISE TEMPERATURE OF SYSTEMS COMPRISING SAMPLES WHICH INTERACT WITH OSCILLATING ELECTROMAGNETIC FIELDS SUPPORTED BY ELECTROMAGNETIC RESONATORS MCANDREW, CHRISTOPHER P —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18570611 SUB-MICRON PARTICLE SHOMER, ISAAC 12d
19106247 METHOD AND APPARATUS FOR REDUCING THE NOISE TEMPERATURE OF SYSTEMS COMPRISING SAMPLES WHICH INTERACT WITH OSCILLATING ELECTROMAGNETIC FIELDS SUPPORTED BY ELECTROMAGNETIC RESONATORS MCANDREW, CHRISTOPHER P —
18998775 IMPLANTABLE DEVICE FOR MONITORING OF HUMAN WELLBEING AND DIFFERENT HEALTH CONDITIONS HANEY, JONATHAN MICHAEL —
18951088 METHOD OF DETERMINING AN ARRANGEMENT FOR OBJECTS PHAM, ANNIE —
18941769 METHOD FOR UPDATING A SCENE REPRESENTATION MODEL NGUYEN, THUY-VI THI —
18836861 NUCLEIC ACID DETECTION WILDER, CYNTHIA B —
18722500 PSEUDOTYPED LENTIVIRAL VECTORS SPENCE, JENNIFER SUZANNE —
18713604 PRODUCTION OF D-LYSERGIC ACID RAGHU, GANAPATHIRAM —

Top Art Units

Art UnitApps
1681 3
1682 3
1633 2
1612 2
1647 2
1618 2
2858 1
3791 1
2662 1
3668 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19106247 METHOD AND APPARATUS FOR REDUCING THE NOISE TEMPERATURE OF SYSTEMS COMPRISING SAMPLES WHICH INTERACT WITH OSCILLATING ELECTROMAGNETIC FIELDS SUPPORTED BY ELECTROMAGNETIC RESONATORS MCANDREW, CHRISTOPHER P 2858 §102§103§112 Non-Final OA — Pending Feb 25, 2025
18998775 IMPLANTABLE DEVICE FOR MONITORING OF HUMAN WELLBEING AND DIFFERENT HEALTH CONDITIONS HANEY, JONATHAN MICHAEL 3791 §102§103 Non-Final OA — Pending Jan 27, 2025
18951088 METHOD OF DETERMINING AN ARRANGEMENT FOR OBJECTS PHAM, ANNIE 2662 §103 Non-Final OA — Pending Nov 18, 2024
18941769 METHOD FOR UPDATING A SCENE REPRESENTATION MODEL NGUYEN, THUY-VI THI 3668 §101§102 Non-Final OA — Pending Nov 08, 2024
18836861 NUCLEIC ACID DETECTION WILDER, CYNTHIA B 1681 §102§103§112 Non-Final OA — Pending Aug 08, 2024
18722500 PSEUDOTYPED LENTIVIRAL VECTORS SPENCE, JENNIFER SUZANNE 1633 §101§103§112 Non-Final OA — Pending Jun 20, 2024
18713604 PRODUCTION OF D-LYSERGIC ACID RAGHU, GANAPATHIRAM 1652 §102§112Other Non-Final OA — Pending May 24, 2024
18691704 microRNA BIOMARKERS GOLDBERG, JEANINE ANNE 1682 §101§102§112 Non-Final OA — Pending Mar 13, 2024
18570611 SUB-MICRON PARTICLE SHOMER, ISAAC 1612 §102§103 Final Rejection 12d Pending Dec 14, 2023
18561853 MULTIPLEX METHODS OF DETECTING MOLECULES USING NANOPORES PRIEST, AARON A 1682 §103 Non-Final OA — Pending Nov 17, 2023
18287556 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS LANDSMAN, ROBERT S 1647 §102§103§112 Non-Final OA — Pending Oct 19, 2023
18287551 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS DUNN, LINDSAY MICHELLE 1644 §102§103§112DP Non-Final OA — Pending Oct 19, 2023
18287542 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS LANDSMAN, ROBERT S 1647 §102§103§112Other Non-Final OA — Pending Oct 19, 2023
18555385 SIGNAL PEPTIDES POPA, ILEANA 1633 §102§103§112 Non-Final OA — Pending Oct 13, 2023
18550354 VOLATILE BIOMARKERS FOR COLORECTAL CANCER BAEK, JONGHWAN NMN 1618 §101§103§112DP Non-Final OA — Pending Sep 13, 2023
18252597 COMPOUNDS FOR THE DETECTION OF HEME OXYGENASE 1 (HO-1), AND METHODS AND USES INVOLVING THE SAME RONEY, CELESTE A 1612 §103 Non-Final OA — Pending May 11, 2023
18248285 METHODS AND MEANS FOR AMPLIFICATION-BASED QUANTIFICATION OF NUCLEIC ACIDS GIAMMONA, FRANCESCA FILIPPA 1681 §101§103 Final Rejection 14d Pending Apr 07, 2023
18024509 TREATMENTS OF DIABETIC ULCERS, RELATED COMPOSITIONS AND KITS PEEBLES, KATHERINE 1617 §103 Non-Final OA — Pending Mar 03, 2023
18042965 A METHOD FOR DETERMINING A DIAGNOSTIC OUTCOME CHUNDURU, SURYAPRABHA 1681 §102§103 Final Rejection 44d overdue Pending Feb 24, 2023
18042285 IDENTIFYING A TARGET NUCLEIC ACID FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§103§112 Non-Final OA — Pending Feb 20, 2023
18016774 ACTUATOR HANDLE FOR SURGICAL TOOLS TON, MARTIN TRUYEN 3771 §102 Final Rejection — Pending Jan 18, 2023
18004125 THERAPEUTIC NUCLEIC ACIDS, PEPTIDES AND USES II KOMATSU, LI N 1658 §103 Final Rejection 29d Pending Jan 03, 2023
18004122 THERAPEUTIC NUCLEIC ACIDS, PEPTIDES AND USES I LEONARD, ARTHUR S 1631 §112 Non-Final OA — Pending Jan 03, 2023
17927491 ANALYTE DETECTION METHOD KENNEDY, SARAH JANE 1682 §103 Non-Final OA — Pending Nov 23, 2022
17917413 CONTROL METHOD FOR MEDICAL VENTILATORS HUSSAIN, MISHAL ZAHRA 3785 §102§103 Final Rejection — Pending Oct 06, 2022
17906602 DEVICE FOR PERFUSION AND PRESERVATION OF TISSUE SPECIMENS EX VIVO KOSAR, AARON J 1655 §102§103 Final Rejection 36d overdue Pending Sep 16, 2022
17798921 DETECTION OF COGNITIVE IMPAIRMENT IN HUMAN BRAINS FROM IMAGES BARNES JR, CARL E 2178 §101§103§112 Final Rejection 45d overdue Pending Aug 11, 2022
17786403 RED BLOOD CELL-DERIVED VESICLE VU, JAKE MINH 1618 §102§103§112 Final Rejection — Pending Jun 16, 2022
17762931 METHOD FOR ISOLATING EXTRACELLULAR VESICLES ZINGARELLI, SANDRA 1653 §103§112 Non-Final OA 34d Pending Mar 23, 2022
17753496 APPARATUS AND METHOD SISON, CHRISTINE ANDREA PAN 3796 §103§112 Final Rejection 18d overdue Pending Mar 04, 2022
17414697 CANCER TREATMENTS CHICKS, ASHLI ARIANA 1626 §112 Non-Final OA — Pending Jun 16, 2021
17260511 SOFT ROBOTIC MANIPULATOR COLLINS, DANIEL S. 3745 §102§103 Non-Final OA — Pending Jan 14, 2021

Managing Imperial College Innovations Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Imperial College Innovations Limited have?

Imperial College Innovations Limited has 32 pending office actions as of October 2026, spread across 24 art units and 31 examiners.

Which USPTO examiner handles the most Imperial College Innovations Limited applications?

Robert S Landsman has the most, with 2 of Imperial College Innovations Limited's pending office actions.

What technology area are Imperial College Innovations Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month